FMC Corporation
0IK3.L
London Stock Exchange11.46
USD
+0.12
- -
FMC Corporation
0IK3.L
(London Stock Exchange)
Recent
price
11.46
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- FMC Corporation (0IK3.L) is a global agricultural sciences company that develops, manufactures and markets crop protection solutions including insecticides, herbicides, fungicides, seed treatments and plant health products to enhance crop yields, quality and resilience for growers worldwide. Founded in 1883 and headquartered in Philadelphia, Pennsylvania, the company operates in more than 100 countries across North America, Latin America including Brazil, Europe, the Middle East, Africa and Asia-Pacific, serving farmers and agricultural producers with science-driven innovations from its industry-leading R&D pipeline featuring proprietary active ingredients, novel biologicals and precision technologies. Core offerings encompass Authority and Command herbicides for weed control; Capture, Talstar and Cynoff insecticides targeting pests; Aim and carfentrazone-ethyl for broadleaf weed management; Authority Broadleaf and sulfentrazone-based soybean herbicides; Rugby for nematode control; seed treatments protecting against soil-borne diseases; and plant health solutions improving environmental stress tolerance. In recent developments, FMC completed the sale of its Global Specialty Solutions business to Envu in late 2024, enabling a sharper focus on core crop protection operations while maintaining a supply partnership for active ingredients; appointed Pierre Brondeau as CEO in June 2024 and Ronaldo Pereira as president; collaborated with Corteva Agriscience to expand fluindapyr fungicide access for U.S. growers; secured registrations for Fundatis herbicide powered by Isoflex active in Great Britain and Dodhylex active in a key Asia-Pacific market; and earlier acquired BioPhero ApS in 2022 to bolster pheromone-based biologicals.